AU Patent

AU2014368927B2 — Cancer treatments using combinations of CDK and ERK inhibitors

Assigned to Biomed Valley Discoveries Inc · Expires 2018-10-25 · 8y expired

What this patent protects

The present invention provides,

USPTO Abstract

The present invention provides,

Drugs covered by this patent

Copiktra (DUVELISIB) · Secura

Patent Metadata

Patent number: AU2014368927B2
Jurisdiction: AU
Classification: —
Expires: 2018-10-25
Drug substance claim: No
Drug product claim: No
Assignee: Biomed Valley Discoveries Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.